Investor Type | Firm |
Type of Fund | Venture Capital Fund |
Industries | Software (Web Marketplace Saas..) • IT (& TMT) • Media • Education • Businesses Solutions • Hardware (& Manufacturing) • Insurance (& InsurTech) • Robotics • Healthcare (& Wellness) • LegalTech • Life Science • Mobile • Mobility • Nanotechnology • Oncology • Consumer |
Stages | Seed, Startup, Early Stage, Expansion,M&A |
Investing | United States • Israel • Europe |
Investment Range | $200,000 - $50,000,000 |
Assets Under Management | $1,300,000,000 |
Partech is a global venture capital firm that operates across Europe, the United States, Africa, and Asia. They have a diverse investment portfolio with specialization in various industries such as Software, IT, Media, Education, Business Solutions, Hardware, Insurance, Robotics, Healthcare, LegalTech, Life Science, Mobile, Mobility, Nanotechnology, Oncology, and Consumer goods. They offer equity investments to startups and early-stage companies, with investment ticket sizes ranging from $200,000 to $50 million. Headquartered in San Francisco, California, Partech has managed to accumulate $1.3 billion in assets under management. Their expertise and commitment to innovation have enabled them to support companies that have accomplished over 21 IPOs and above 50 strategic mergers and acquisitions valued at more than $100 million. Partech prides itself on independent thinking and action, providing ambitious motion to entrepreneurs and backing them with a collective of expert knowledge for global reach. With their specialities in Seed, Startup, Early Stage, Expansion, and M&A, they aim to drive responsible investment and growth across their portfolio. Founded in 1982 in Silicon Valley, the firm brings deep industry insights and a commitment to investing responsibly, reflected in their strategies and sustainability philosophy. Their investments in companies like Quibim, which has raised $50 million in Series A financing, and Shippeo, with its $30 million funding round, highlight their strategic focus on technology-driven businesses and their ambitious expansion plans in precision medicine and transportation logistics.